These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 5602266)

  • 21. Synergism exhibited by LTD4 and PAF receptor antagonists in decreasing antigen-induced airway microvascular leakage.
    Wasserman MA; Welton AF; Renzetti LM
    Adv Prostaglandin Thromboxane Leukot Res; 1995; 23():271-3. PubMed ID: 7732851
    [No Abstract]   [Full Text] [Related]  

  • 22. Initial SAR studies on apamin-displacing 2-aminothiazole blockers of calcium-activated small conductance potassium channels.
    Gentles RG; Grant-Young K; Hu S; Huang Y; Poss MA; Andres C; Fiedler T; Knox R; Lodge N; Weaver CD; Harden DG
    Bioorg Med Chem Lett; 2008 Oct; 18(19):5316-9. PubMed ID: 18774291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A rational chemical intervention strategy to circumvent bioactivation liabilities associated with a nonpeptidyl thrombopoietin receptor agonist containing a 2-amino-4-arylthiazole motif.
    Kalgutkar AS; Driscoll J; Zhao SX; Walker GS; Shepard RM; Soglia JR; Atherton J; Yu L; Mutlib AE; Munchhof MJ; Reiter LA; Jones CS; Doty JL; Trevena KA; Shaffer CL; Ripp SL
    Chem Res Toxicol; 2007 Dec; 20(12):1954-65. PubMed ID: 17935300
    [TBL] [Abstract][Full Text] [Related]  

  • 24. General pharmacology of KB-944, a new calcium antagonist.
    Morita T; Fukuda T; Sukamoto T; Tajima S; Sato I; Ikeda Y; Kanazawa T; Hamada Y; Morimoto Y; Kitamura H; Kawakami K; Ito K; Nose T
    Arzneimittelforschung; 1982; 32(9):1060-8. PubMed ID: 6890827
    [No Abstract]   [Full Text] [Related]  

  • 25. Mass spectrometry of 2-substituted-4-arylthiazoles. II--Identification of microsomal nitroreduction product by mass spectrometry.
    Mattammal MB; Zenser TV; Davis BB
    Biomed Mass Spectrom; 1982 Sep; 9(9):376-80. PubMed ID: 7139057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Accidents and accidents during aminothiazole therapy].
    BUTTARO CA
    Riforma Med; 1949 Aug; 63(33):788-92. PubMed ID: 18143762
    [No Abstract]   [Full Text] [Related]  

  • 27. [The modelling of hyperfermentemia--a method for studying the mechanisms of the formation of metabolic disorders].
    Gil'miiarova FN; Radomskaia VM; Golenishchev VIu; Mirzaev BS; Romanova IuV; Fesenko VA
    Biull Eksp Biol Med; 1993 Oct; 116(10):376-8. PubMed ID: 8117955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hit-to-Lead studies: the discovery of potent, orally bioavailable thiazolopyrimidine CXCR2 receptor antagonists.
    Baxter A; Cooper A; Kinchin E; Moakes K; Unitt J; Wallace A
    Bioorg Med Chem Lett; 2006 Feb; 16(4):960-3. PubMed ID: 16297626
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MAO-A-induced mitogenic signaling is mediated by reactive oxygen species, MMP-2, and the sphingolipid pathway.
    Coatrieux C; Sanson M; Negre-Salvayre A; Parini A; Hannun Y; Itohara S; Salvayre R; Auge N
    Free Radic Biol Med; 2007 Jul; 43(1):80-9. PubMed ID: 17561096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Enzyme activity of thiamine pyrophosphate in the rat after oxythiamine administration].
    Strumilo SA; Senkevich SB; Galitskiĭ EA; Vinogradov VV
    Biull Eksp Biol Med; 1983 Nov; 96(11):42-4. PubMed ID: 6640096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and pharmacological evaluation of 6,7-indolo/thiazolo-morphinans--further SAR of levorphanol.
    Zhang A; Li F; Ding C; Yao Q; Knapp BI; Bidlack JM; Neumeyer JL
    J Med Chem; 2007 May; 50(11):2747-51. PubMed ID: 17488103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanism of FANFT cooxidation by prostaglandin endoperoxide synthetase.
    Zenser TV; Mattammal MB; Davis BB
    J Pharmacol Exp Ther; 1980 Aug; 214(2):312-7. PubMed ID: 6771392
    [No Abstract]   [Full Text] [Related]  

  • 33. [Thiazole derivatives. V. Synthesis and pharmacological screening of amides of 4-phenyl-5-thiazolecarboxylic acids].
    Zawadzka J; Bogdal M
    Acta Pol Pharm; 1984; 41(6):633-40. PubMed ID: 6536187
    [No Abstract]   [Full Text] [Related]  

  • 34. Synthesis, antiarrhythmic and anticoagulant activities of novel thiazolo derivatives from methyl 2-(thiazol-2-ylcarbamoyl)acetate.
    Amr Ael-G; Sabrry NM; Abdalla MM; Abdel-Wahab BF
    Eur J Med Chem; 2009 Feb; 44(2):725-35. PubMed ID: 18579260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of thiazolidinediones and metformin on LDL oxidation and aortic endothelium relaxation in diabetic GK rats.
    Iida KT; Kawakami Y; Suzuki M; Shimano H; Toyoshima H; Sone H; Shimada K; Iwama Y; Watanabe Y; Mokuno H; Kamata K; Yamada N
    Am J Physiol Endocrinol Metab; 2003 Jun; 284(6):E1125-30. PubMed ID: 12569086
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The physiological response of experimental animals following absorption of 2-aminothiazole.
    DEICHMANN WB; KITZMILLER KV
    J Ind Hyg Toxicol; 1948 Mar; 30(2):71-8. PubMed ID: 18905196
    [No Abstract]   [Full Text] [Related]  

  • 37. [QUANTITATIVE DETERMINATION OF OXIDATION INSUFFICIENCY IN METABOLIC DISEASES].
    PFLEIDERER H; REIS A; EIBER H
    Klin Wochenschr; 1964 Sep; 42():921-2. PubMed ID: 14318195
    [No Abstract]   [Full Text] [Related]  

  • 38. [Toxicity of aminothiazole].
    TINACCI F; IGNESTI G
    Sperimentale; 1951 Apr; 101(3-4):100-17. PubMed ID: 14866626
    [No Abstract]   [Full Text] [Related]  

  • 39. [Aminothiazole, antithyroid of synthesis].
    SANTIAGO SCLAFER
    Dia Med; 1948 Jul; 20(38):1413-6. PubMed ID: 18883124
    [No Abstract]   [Full Text] [Related]  

  • 40. t-Aminoalkyl derivatives of 2-aminothiazole.
    LAND AH; ZIEGLER C; SPRAGUE JM
    J Am Chem Soc; 1947 Jan; 69(1):125-8. PubMed ID: 20291050
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.